MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION.
D015068:17-Ketosteroids; D000315:Adrenalectomy; D000450:Aldosterone; D035843:Biomedical Research; D001826:Body Fluids; D003345:Corticosterone; D003907:Dexamethasone; D004358:Drug Therapy; D004573:Electrolytes; D005441:Fluids and Secretions; D006929:Hyperaldosteronism; D007659:Ketones; D008660:Metabolism; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis; D010084:Oxidation-Reduction; D011188:Potassium; D011725:Pyridines; D014556:Urine
D015068:17-Ketosteroids; D004573:Electrolytes; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D011725:Pyridines; D000450:Aldosterone; D003907:Dexamethasone; D011188:Potassium; D003345:Corticosterone
17-KETOSTEROIDS; ADRENALECTOMY; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; CLINICAL RESEARCH; CORTICOSTERONE; DEXAMETHASONE; DRUG THERAPY; EXCRETION; HYPERALDOSTERONISM; KETONES; METABOLISM; NATRIURESIS; OXIDATION-REDUCTION; POTASSIUM; PYRIDINES; URINE